Arginase induction promotes Trypanosoma cruzi intracellular replication of Cruzipain-treated J774 cells through the activation of multiple signaling pathways

European Journal of Immunology

Volumn 34, Issue 1, 2004, Pages 200-209

  Stempin, Cinthia C ^a   Tanos, Tamara B ^b   Coso, Omar A ^b   Cerbán, Fabio M ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Arginase; Macrophage; Parasite antigen; Protein kinase; Trypanosoma cruzi

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ARGINASE; ARGININE; CALPHOSTIN C; CARBAZOLE DERIVATIVE; CRUZIPAIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYSTEINE PROTEINASE; DRUG DERIVATIVE; GENISTEIN; GROWTH INHIBITOR; IMIDAZOLE DERIVATIVE; INDOLE DERIVATIVE; KT 5720; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; N(G) HYDROXYARGININE; N(OMEGA) HYDROXYARGININE; N(OMEGA)-HYDROXYARGININE; NITRIC OXIDE; PARASITE ANTIGEN; PROTEIN KINASE C INHIBITOR; PROTEIN P42; PROTEIN P44; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; PYRIDINE DERIVATIVE; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG; UREA;

AMASTIGOTE; AMINO ACID METABOLISM; ANIMAL; ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CELL DIVISION; CELL LINE; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITION; ENZYMOLOGY; GROWTH, DEVELOPMENT AND AGING; INCUBATION TIME; MACROPHAGE; METABOLISM; MOUSE; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRYPANOSOMA CRUZI;

ANIMALS; ARGINASE; ARGININE; CARBAZOLES; CELL DIVISION; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYSTEINE ENDOPEPTIDASES; ENZYME INDUCTION; GENISTEIN; GROWTH INHIBITORS; IMIDAZOLES; INDOLES; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-TYROSINE KINASES; PYRIDINES; PYRROLES; SIGNAL TRANSDUCTION; TRYPANOSOMA CRUZI;

EID: 1642554787     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324313     Document Type: Article

References (45)

1. Tanowitz, H., Kirchhoff, L., Simon, D., Morris, S., Wiess, L. and Wittner, M., Chagas disease. Clin. Microbiol. Rev. 1992. 5: 400-419.
2. Seljelid, R. and Eskeland, T., The biology of macrophage: I. General principles and properties. Eur. J. Haematol. 1993. 51: 267-275.
3. Hibbs, J. B. Jr., Taintor, R. R., Vavrin, Z. and Rachlin, E. M., Nitric Oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 1988. 157: 87-94.
4. Aderem, A. and Ulevitch, R. J., Toll-like receptors in the induction of the innate immune response. Nature 2000. 406: 782-787.
5. Goerdt, S. and Orfanos, C. E., Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999. 10: 137-142.
6. Gordon, S., Alternative activation of macrophages. Nat. Rev. Immunol. 2003. 3: 23-35.
7. + T cells correlates with Th1/Th2 phenotype. J. Immunol. 1998. 160: 5347-5354.
8. Saheki, T., Sato, Y., Takada, S. and Katsunuma, T., Regulation of urea synthesis in rat liver. J. Biochem. 1979. 86: 745-750.
9. Gotoh, T., Sonoki, T., Nagasaki, A., Terada, K., Takiguchi, M. and Mori, M., Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line. FEBS Lett. 1996. 395: 119-122.
10. Wang, W. W., Jenkinson, C. P., Griscavage, J. M., Kern R. M., Arabolos, N. S., Byrns, R. E., Cederbaum, S. D. and Ignarro, L. J., Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochem. Biophys. Res. Commun. 1995. 210: 1009-1016.
11. Aminlari, M. and Vaseghi, T., Arginase distribution in tissues of domestic animals. Comp. Biochem. Physiol. B. 1992. 103: 385-389.
12. Vockley, J. G., Jenkinson, C. P., Shukla, H., Kern, R. M., Grody, W. W. and Cederbaum, S. D., Cloning and characterization of the human type II arginase gene. Genomics 1996. 38: 118-123.
13. Sonoki, T., Nagasaki, A., Gotoh, T., Takiguchi, M., Takeya, M., Matsuzaki, H. and Mori, M., Coinduction of nitric-oxide synthase and arginase I in cultured rat peritoneal macrophages and rat tissues in vitro by lipopolysaccharide. J. Biol. Chem. 1997. 272: 3689-3693.
14. Boutard, V., Havouis, R., Fouqueray, B., Philippe, C., Moulinoux, J. P. and Baud, L., Transforming growth factor beta stimulates arginase activity in macrophages: implications for the regulation of macrophage cytotoxicity. J. Immunol. 1995. 155: 2077-2084.
15. Waddington, S. N., Tam F. W. K., Cook, H. T. and Cattell, V., Arginase activity is modulated by IL-4 and HOArg in nephritic glomeruli and mesangial cells. Am. J. Physiol. Renal Physiol. 1998. 274: 473-480.
16. Corraliza, I. M., Soler, G., Eichmann, K. and Modolell, M., Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages. Biochem. Biophys. Res. Comm. 1995. 206: 667-673.
17. Modolell, M., Corraliza, I. M., Link, F., Soler, G. and Eichmann, K., Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by Th1 and Th2 cytokines. Eur. J. Immunol. 1995. 25: 1101-1104.
18. Louis, C. A., Mody, V., Henry W. L., Reichner, J. S. and Albina, J. E. Jr., Regulation of arginase isoforms I and II by IL-4 in cultured murine peritoneal macrophages. Am. J. Physiol. Regul. Integrative Comp. Physiol. 1999. 276: 237-242.
19. Chang, C. I., Zoghi, B., Liao, J. C. and Kuo, L., The involvement of tyrosine kinases, cyclic AMP/protein kinase A, and p38 mitogen-activated protein kinase in IL-13-mediated arginase I induction in macrophages: its implications in IL-13-inhibited nitric oxide production. J. Immunol. 2000. 165: 2134-2141.
20. Munder, M., Eichmann, K., Morán, J. M., Centeno, F., Soler, G. and Modolell, M., Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J. Immunol. 1999. 163: 3771-3777.
21. Stempin, C., Giordanengo, L., Gea, S. and Cerbán, F., Alternative activation and increase of Trypanosoma cruzi survival in murine macrophages stimulated by cruzipain, a parasite antigen. J. Leukoc. Biol. 2002. 72: 727-734.
22. Carrera, L., Gazzinelli, R. T., Badolato, R., Hieny, S., Muller, W., Jun, R. and Sacks, D. L., Leishmania promastigotes selectively inhibit interleukin-12 induction in bone-marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med. 1996. 183: 515-526.
23. Butcher, B. A., Kim, L., Johnson, P. F. and Denkers, E. Y., Toxoplasma gondii tachyzoites inhibit proinflamatory cytokine induction in infected macrophages by prevening nuclear translocation of the transcription factor NFkB. J. Immunol. 2001. 167: 2193-2201.
24. Denkers, E. Y., Kim, L. and Butcher, B. A., In the belly of the beast: subversion of macrophage proinflamatory signaling cascades during Toxoplasma gondii infection. Cell. Microbiol. 2003. 5: 75-83.
25. Roach, S. K. and Schorey, J. S., Differential regulation of the mitogen-activated protein kinases by pathogenic and nonpathogenic mycobacteria. Infect. Immun. 2002. 70: 3040-3052.
26. Schorey, J. S. and Cooper, A. M., Macrophage signaling upon mycobacterial infection: the MAP kinases lead the way. Cell. Microbiol. 2003. 5: 133-142.
27. Lahti, A., Lahde, M., Kankaanranta, H. and Moilanen, E., Inhibition of extracellular signal-regulated kinase suppresses endotoxin-induced nitric oxide synthesis in mouse macrophages and in human colon epithelial cells. J. Pharmacol. Exp. Ther. 2000. 294: 1188-1194.
28. Nathan, C. and Xie, Q. W., Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 1994. 269: 13725-13728.
29. Wang, Y. and Marsden, P. A., Nitric oxide synthases: gene structure and regulation. Adv. Pharmacol. 1995. 34: 71-90.
30. Iniesta, V., Gomez Nieto, C. and Corraliza, I., The inhibition of arginase by N-omega-hydroxy-L-arginine controls the growth of Leishmania inside macrophages. J. Exp. Med. 2001. 193: 777-783.
31. Gobert, A., Daulouede, S., Lepoivre, M., Boucher, J., Bouteille, B., Buguet, A., Cespuglio, R., Veyret, B. and Vincendau, P., L-Arginine availability modulates local nitric oxide production and parasite killing in experimental trypanosomiasis. Infect. Immun. 2000. 68: 4653-4657.
32. Wei, S., Marches, F., Daniel, B., Sonda, S., Heidenreich, K. and Curiel, T., Pyridinylimidazole p38 mitogen-activated protein kinase inhibitors block intracellular Toxoplasma gondii replication. Int. J. Parasitol. 2002. 32: 969-977.
33. Junghae, M. and Raynes, J. G., Activation of p38 mitogen-activated protein kinase attenuates Leishmania donovani infection in macrophages. Infect. Immun. 2002. 70: 5026-5035.
34. Welham, M. J., Learmonth, L., Bone, H. and Schrader, J. W., Interleukin-13 signal transduction in lymphohemopoietic cells. Similarities and differences in signal transduction with interleukin-4 and insulin. J. Biol. Chem. 1995. 270: 12286-12296.
35. Raingeaud, J., Whitmarsh, A. J., Barrett, T., Derijard, B. and Davis, R. J., MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 1996. 16: 247-255.
36. Chen, K. D., Chen, L. Y., Huang, H. L., Lieu, C. H., Chang, Y. N., Chang, M. D. and Lai, Y. K., Involvement of p38 mitogen-activated protein kinase signaling pathway in the rapid induction of the 78-kDa glucose-regulated protein in 9L rat brain tumor cells. J. Biol. Chem. 1998. 273: 749-755.
37. Vincendeau, P., Gobert, A. P., Daulouede, S., Moynet, D. and Mossalayi, M. D., Arginases in parasitic diseases. Trends Parasitol. 2003. 19: 9-12.
38. Hesse, M., Modollel, M., La Flamme, A. C., Schito, M., Fuentes, J. M., Cheever, A. W., Pearce, E. J. and Wynn, T. A., Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 2001. 167: 6533-6544.
39. Abdallahi, O. M., Bensalem, H., Augier, R., Diagana, M., De Reggi, M. and Gharib, B., Arginase expression in peritoneal macrophages and increase in circulating polyamine levels in mice infected with Schistosoma mansoni. Cell. Mol. Life Sci. 2001. 58: 1350-1357.
40. Namangala, B., De Baetselier, P., Noël, W., Brys, L. and Beschin, A., Alternative versus classical macrophage activation during experimental African trypanosomosis. J. Leukoc. Biol. 2001. 69: 387-396.
41. Giordanengo, L., Guiñazu, N., Stempin, C., Fretes, R., Cerban, F. and Gea, S., Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite. Eur. J. Immunol. 2002. 32: 1003-1011.
42. Labriola, C., Souza, M. and Cazzulo, J. J., Purification of the major cystein proteinase (cruzipain) from Trypanosoma cruzi by affinity chromatography. Biol. Res. 1993. 26: 101-107.
43. Campetella, O., Martinez, J. and Cazzulo, J. J., A major cystein proteinase is developmentally regulated in Trypanosoma cruzi. FEMS Microbiol. Lett. 1990. 55: 145-149.
44. Cazzulo, J. J., Couso, R., Raimondi, A., Wernstedt, C. and Hellman, U., Further characterization and partial amino acid sequence of a cystein proteinase from Trypanosoma cruzi. Mol. Biochem. Parasitol. 1989. 33: 33-42.
45. Corraliza, I. M., Campo, M. L., Soler, G. and Modollel, M., Determination of arginase activity in macrophages: a micro-method. J. Immunol. Methods 1994. 174: 231-235.